Public Advisories

July 2008 - Desmopressin nasal sprays, (including Apo-Desmopressin Spray), are associated with an increased risk of serious side effects involving water retention and decreased blood sodium levels (hyponatremia).

January 2005 - Important safety information for patients taking Apo-Mefloquine (mefloquine) for the prevention of malaria.